HPS Pharmacies wish to advise that Arrow Pharma is discontinuing Capoten® Oral Liquid as follows:
Capoten® Oral Liquid
Captopril 5mg/mL
ARTG 68962
Capoten® Oral Liquid may still be available in some warehouses until current supplies are exhausted.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989 until 30 April 2024. This product is identical to the Australian registered product for active ingredient and strength. However, there are some presentation differences, as shown in the table below.
| Capoten® | S19A Product | |
| Administration | Give on empty stomach | Give without regards to meals |
| Storage | Refrigerate (2°C to 8°C) | Do not store above 30°C |
| Expiry | Discard 28 days after opening | Discard 21 days after opening |
| Excipients | Citric acid
Disodium edetate Hydrochloric acid Purified water Sodium benzoate Sodium citrate dihydrate Sodium hydroxide |
Sodium benzoate (E211)
Citric acid monohydrate (E330) Sodium citrate (E331) Disodium edetate Purified water |
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Arrow Pharma on 1800 195 055 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates